Gene Solutions Strengthens China Footprint with Strategic Partnerships in Precision Oncology
BEIJING, June 20, 2025 /PRNewswire/ -- Gene Solutions announces the signing of two strategic Memoranda of Understanding (MOUs) with ZaoDx and Xiong'an MagicBiotech Co., Ltd. These partnerships mark a focused expansion of Gene Solutions' precision...
Gene Solutions and Shenzhen USK Bioscience Forge Strategic Partnership to Establish Next-Generation Sequencing Laboratory in Southern China
SINGAPORE, June 14, 2025 /PRNewswire/ -- Gene Solutions, a leading multinational biotechnology company and Shenzhen USK Bioscience Co., Ltd. (USKBio), a prominent innovator in molecular diagnostics, have entered a strategic partnership through a...
Gene Solutions and Topgen Join Forces to Advance Precision Oncology All Over China
SHANGHAI, June 12, 2025 /PRNewswire/ -- Gene Solutions has formalized a strategic collaboration with Zhejiang Shaoxing Topgen Biomedical Technology Co. , Ltd., a CAP-accredited laboratory with a well-established footprint across all over China....
Gene Solutions and NEWCL Forge Strategic Partnership to Advance Genetic Testing in Taiwan
NEW TAIPEI CITY, May 16, 2025 /PRNewswire/ -- In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Laboratory, Taiwan's pioneering clinical laboratory with LDTs certification, have joined...
GENE SOLUTIONS AND ELEMENT BIOSCIENCES ENTER STRATEGIC COLLABORATION TO ADVANCE NEXT-GENERATION SEQUENCING (NGS) TECHNOLOGY GLOBALLY
HO CHI MINH CITY, April 22, 2025 /PRNewswire/ -- Gene Solutions, a leading multinational biotech company specializing in advanced genetic testing, and Element Biosciences, a company democratizing access to advanced life science solutions, have...
Gene Solutions Leads the Way in Cancer Early Detection with Asia's First Clinical Validated Multi-Cancer Blood Test
SINGAPORE, March 26, 2025 /PRNewswire/ -- Gene Solutions, a leading biotech company in Asia, proudly announces a groundbreaking achievement in cancer early detection. The company's innovative SPOT-MAS test has become the first multi-cancer screening...
AI & Genomics Advances Bring New Hope to Lung Cancer Burden in Asia
SINGAPORE, Feb. 5, 2025 /PRNewswire/ -- Asia is the region most impacted by lung cancer, accounting for 63.1% of newly diagnosed lung cancers and 62.9% of lung cancer deaths worldwide(1). Many countries have applied low-dose CT scans to screen for...
Skyee Receives In-Principle Approval (IPA) for Major Payment Institution License (MPI) from the Monetary Authority of Singapore (MAS)
SINGAPORE, Jan. 13, 2025 /PRNewswire/ -- Skyee Pte. Ltd. ("Skyee") is excited to announce that it has been granted In-Principle Approval (IPA) for the Major Payment Institution (MPI) license from the Monetary Authority of Singapore (MAS). Skyee is a...